Dupixent is prescribed to people with atopic dermatitis, and other allergic medical conditions. This includes asthma, nasal polyps leading to chronic sinusitis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease (COPD).
Research reveals that the active ingredient, dupilumab, in your Dupixent injection can cause CTCL skin cancer. It can also make you worse if you already had skin cancer. We are suing the manufacturers, Regeneron Pharmaceuticals and Sanofi-Aventis, for not warning people of this risk.
CTCL develops in white blood cells that are part of your immune system. CTCL is also known as mycosis fungoides, Sézary syndrome, lymphomatoid papulosis, subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, extranodal NK/T-cell lymphoma, and primary cutaneous gamma/delta T-cell lymphoma.
We have helped more than 44,000 clients deal with cancers that threaten their health. We’ve won billions of dollars for them in verdicts and settlements.
If you used Dupixent, and are suffering from CTCL skin cancer, you may be eligible for compensation. Compensation may encompass your medical expenses, as well as compensation for any pain and suffering. Additionally, you may be entitled to financial remuneration for any loss of earnings and future lost income.
Weitz & Luxenberg is a nationwide law firm, with decades of experience, specializing in legal services tailored to clients who have been wrongfully injured. Weitz & Luxenberg is dedicated to helping people who have been wrongfully injured by another’s negligence get the justice and compensation they deserve. With nearly four decades of experience in mass tort and personal injury litigation, we understand what it takes to advocate for the rights of consumers and their families. We have a proven track record of success, recovering more than $26 billion in verdicts and settlements for over 100,000 clients nationwide. The experience, compassion, and resources we offer are largely unparalleled.
Co-Founders Perry Weitz and Arthur Luxenberg created a firm dedicated to practicing law at the highest level for the most vulnerable. Since 1986, they have revolutionized asbestos litigation while fighting for mesothelioma and lung cancer victims and have applied their mass tort litigation innovations towards the pursuit of badly needed justice for Americans injured by defective drugs and medical devices, toxic environmental pollution, and a wide range of defective products.
Perry Weitz
Co-Founding Member
Mesothelioma and Asbestos
Perry Weitz is the firm’s chief negotiator, having crafted more than 1,000 settlements benefiting Weitz & Luxenberg clients during his career. His groundbreaking legal strategies made him a pioneer of asbestos litigation in America, while his legal skills have secured more than $7 billion in verdicts and settlements for clients.
Arthur Luxenberg
Co-Founding Member
Mesothelioma and Asbestos
Arthur Luxenberg redefined asbestos litigation with groundbreaking appellate strategies early in his career. Mr. Luxenberg continues to bring finely tuned strategic skills to managing the daily operations of scores of attorneys and hundreds of specialists as he shepherds thousands of active cases to courtrooms and settlement negotiations.
Robin L. Greenwald
Practice Group Chair
Charles M. Ferguson
Practice Group Chair
Ellen Relkin
Practice Group Chair
James Bilsborrow
Practice Group Chair
Gary R. Klein
Practice Group Chair
We have four strategically placed locations across the country that enable us to effectively serve clients from every single state in the union.
Your path to justice starts here. Let our experienced legal advocate team assess your situation with a free case evaluation.